Showing results (91-100 of 127) with videos related to
Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|October 18, 2019
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccineCaterina Lapenta, Simona Donati, Francesca Spadaro, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell responseLaura Santodonato, Giuseppina D'Agostino, Roberto Nisini, et al.Vaccine|April 13, 2011
MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68Eleonora Aricò, Domenica M Monque, Giuseppina D'Agostino, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
A type I IFN-dependent pathway induced by Schistosoma mansoni eggs in mouse myeloid dendritic cells generates an inflammatory signatureFrançois Trottein, Norman Pavelka, Caterina Vizzardelli, et al.Neoplasia (New York, N.Y.)|January 12, 2013
IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironmentFabrizio Mattei, Giovanna Schiavoni, Paola Sestili, et al.Journal of Translational Medicine|February 14, 2008
The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forwardMichele Maio, Hugues Jm Nicolay, Paolo Ascierto, et al.Cancer Research|December 16, 2010
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosisGiovanna Schiavoni, Antonella Sistigu, Mara Valentini, et al.Journal of Immunotoxicology|March 7, 2014
A multidisciplinary study using in vivo tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cellsFabrizio Mattei, Giovanna Schiavoni, Adele De Ninno, et al.Plos One|August 27, 2013
IFN-α regulates Blimp-1 expression via miR-23a and miR-125b in both monocytes-derived DC and pDCStefania Parlato, Roberto Bruni, Paola Fragapane, et al.Frontiers in Oncology|June 5, 2023
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alphaFederica Moschella, Carla Buccione, Irene Ruspantini, et al.Pageof 13